Search research articles
Contact Us
Filters
Showing results (101-110 of 185) with videos related to
Page
of 19
Sort By:
Leukemia & Lymphoma
|
June 23, 2017
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide
Rossana Maffei, Stefania Fiorcari, Silvia Martinelli, et al.
Hematological Oncology
|
March 8, 2018
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding
Giuseppe Boriani, Paolo Corradini, Antonio Cuneo, et al.
Oncotarget
|
April 22, 2017
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness
Gian Matteo Rigolin, Luca Formigaro, Maurizio Cavallari, et al.
Experimental Hematology
|
November 12, 2013
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia
Rossana Maffei, Stefania Fiorcari, Jenny Bulgarelli, et al.
BMJ Supportive & Palliative Care
|
May 4, 2021
Fatigue in newly diagnosed acute myeloid leukaemia: general population comparison and predictive factors
Laura B Oswald, Adriano Venditti, David Cella, et al.
Blood
|
January 17, 2012
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: correlations with clinicobiologic parameters
Gian Matteo Rigolin, Francesca Cibien, Sara Martinelli, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
November 23, 2016
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy
Sara Martinelli, Antonio Cuneo, Luca Formigaro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 5, 2010
Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis
Fausto Castagnetti, Nicoletta Testoni, Simona Luatti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 31, 2013
Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation
Francesco Lanza, Diana C Campioni, Andrzej Hellmann, et al.
Oncotarget
|
October 23, 2018
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia
Maurizio Cavallari, Francesco Cavazzini, Antonella Bardi, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 185) with videos related to
Sort By:
Page
of 19
Leukemia & Lymphoma
|
June 23, 2017
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide
Rossana Maffei, Stefania Fiorcari, Silvia Martinelli, et al.
Hematological Oncology
|
March 8, 2018
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding
Giuseppe Boriani, Paolo Corradini, Antonio Cuneo, et al.
Oncotarget
|
April 22, 2017
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness
Gian Matteo Rigolin, Luca Formigaro, Maurizio Cavallari, et al.
Experimental Hematology
|
November 12, 2013
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia
Rossana Maffei, Stefania Fiorcari, Jenny Bulgarelli, et al.
BMJ Supportive & Palliative Care
|
May 4, 2021
Fatigue in newly diagnosed acute myeloid leukaemia: general population comparison and predictive factors
Laura B Oswald, Adriano Venditti, David Cella, et al.
Blood
|
January 17, 2012
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: correlations with clinicobiologic parameters
Gian Matteo Rigolin, Francesca Cibien, Sara Martinelli, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
November 23, 2016
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy
Sara Martinelli, Antonio Cuneo, Luca Formigaro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 5, 2010
Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis
Fausto Castagnetti, Nicoletta Testoni, Simona Luatti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 31, 2013
Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation
Francesco Lanza, Diana C Campioni, Andrzej Hellmann, et al.
Oncotarget
|
October 23, 2018
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia
Maurizio Cavallari, Francesco Cavazzini, Antonella Bardi, et al.
Page
of 19